CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
LRCX posted impressive Mar-Q results with sales of $5.84B (+24% Y/Y) and non-GAAP EPS of $1.47 (+41%), beating Street expectations of $5.76B / $1.36. Systems revenue grew 23% Y/Y (vs. +28% last Q) while CSBG sales accelerated to 25% growth (from +14%), reflecting continued strong AI spending momentum. We see continued upside as elevated memory prices drive equipment purchases that should benefit LRCX in the coming quarters. Management provided strong Jun-Q guidance of $6.6B sales (vs. $6.0B Street) and $1.65 EPS (vs. $1.45), while raising its CY 26 WFE outlook to $140B+ from $135B, implying 27% industry growth despite supply constraints. China sales remain elevated at 36% of Mar-Q revenue (+100 bps Q/Q, +500 bps Y/Y), reflecting vulnerability to potential export control tightening and accelerating self-sufficiency efforts (though robust demand ex-China still supports strong growth). Non-GAAP gross margin of 49.9% and operating margin of 35.0% both easily exceeded guidance midpoints (49.0% / 34.0%).